A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2011
08/18/2011	WO2011100477A2 Antibodies and processes for preparing the same
08/18/2011	WO2011100408A2 Serologic correlates of protection against bacillis anthracis infection
08/18/2011	WO2011100354A1 Removal of virulence factors through extracorporeal therapy
08/18/2011	WO2011100234A2 Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods
08/18/2011	WO2011099886A1 Β-carbonyl derivatives having anti-tuberculosis activity
08/18/2011	WO2011099812A2 Composition for preventing or treating rotavirus infection containing licorice extract
08/18/2011	WO2011099804A2 Novel antifungal triazole derivatives
08/18/2011	WO2011099665A1 Antimicrobial composition containing extracts from natural ingredients, natural composite antiseptics, and method for manufacturing same
08/18/2011	WO2011099514A1 Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
08/18/2011	WO2011098829A1 Nucleic acid complexes
08/18/2011	WO2011098806A1 Proteins of the jak, stat, socs and pias families for use in the treatment hypercytokinemia or viral infection
08/18/2011	WO2011098579A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention
08/18/2011	WO2011098452A1 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate
08/18/2011	WO2011098451A1 Purine derivatives and their pharmaceutical uses
08/18/2011	WO2011097958A1 Oral carbapenem compounds containing aminosulfonyl azetidinyl
08/18/2011	WO2011097950A1 6-o-methylerythromycin 9-o-(3-hetroaryl-2-propenyl) oxime ketolide derivatives, preparation methods and pharmaceutical compositions thereof
08/18/2011	WO2011097946A1 Oxazolidinone compounds containing ring-fused bicyclic ring, preparation method and use thereof
08/18/2011	WO2011097750A1 Compositions, products, therapeutic uses and procedures for the production and/or crystallisation of extracts of encelia canescens lam (coronilla de fraile)
08/18/2011	WO2011097733A1 Free hexasaccharide isolated from several campylobacter species
08/18/2011	WO2011097688A1 Protein domains and uses therefor
08/18/2011	WO2011082388A3 Infectious dna vaccines against chikungunya virus
08/18/2011	WO2011079249A3 Vitamin d glycosides and sulfates for treating diseases
08/18/2011	WO2011079234A3 Highly permeating terbinafine formulation for treating onychomycosis
08/18/2011	WO2011076923A9 Inhibitor for inosine monophosphate (imp) dehydrogenase and/or viral rna polymerase for treatment of hepatitis e
08/18/2011	WO2011072336A8 Antiviral agents
08/18/2011	WO2011057160A8 Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
08/18/2011	WO2011050098A3 Compositions, methods and uses for inhibition and/or treatment of influenza infection
08/18/2011	WO2011047323A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	WO2011047320A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	WO2011047319A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	WO2011046946A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
08/18/2011	WO2011044576A3 Selectively disrupted whole-cell vaccine
08/18/2011	WO2011044505A3 Enzyme inhibiting compounds and methods
08/18/2011	WO2011044499A3 Enterotoxigenic e. coli fusion protein vaccines
08/18/2011	WO2011035120A3 Therapeutic composition to treat lesions caused by herpes simplex virus
08/18/2011	WO2011031471A3 The fungal srebp pathway as a target for anti-fungal agents
08/18/2011	WO2011028963A3 Immunogenic hiv composition
08/18/2011	WO2011020879A3 Use of an extract obtained from plants of the sub-family rutoideae in the treatment of cancer
08/18/2011	WO2011019932A3 Compositions and methods for the therapy and diagnosis of influenza
08/18/2011	US20110202025 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis
08/18/2011	US20110201693 Hydroalcoholic antimicrobial composition with skin health benefits
08/18/2011	US20110201689 Compositions containing quaternary ammonium compounds
08/18/2011	US20110201671 Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus
08/18/2011	US20110201667 Compositions and methods for silencing ebola virus gene expression
08/18/2011	US20110201666 Compounds from mycelium of antrodia cinnamomea and use thereof
08/18/2011	US20110201665 Compositions, Methods, and Kits for Treating Influenza Viral Infections
08/18/2011	US20110201657 Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
08/18/2011	US20110201648 Poly-heteroaryl derivatives for the treatment of cancer
08/18/2011	US20110201647 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifluoromethoxy-1h-indol-3-yl]-methanone as an inhibitor of mast cell tryptase
08/18/2011	US20110201643 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
08/18/2011	US20110201604 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
08/18/2011	US20110201595 Oxazolidinyl antibiotics
08/18/2011	US20110201587 Hsp90 inhibitors and methods of use
08/18/2011	US20110201585 The Use of Oestrogen Applied to the Penis to Reduce HIV Infections
08/18/2011	US20110201577 Processes and intermediates for the preparation of oseltamivir and analogs thereof
08/18/2011	US20110201575 Stabilized solid dispersion of adefovir dipivoxil and preparation method thereof
08/18/2011	US20110201566 Methods for treating resistant diseases using triazole containing macrolides
08/18/2011	US20110201548 Therapeutic agent for acute hepatitis or prophylactic/therapeutic agent for fulminant hepatitis
08/18/2011	US20110201547 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
08/18/2011	US20110201546 Methods of treatment using single doses of oritavancin
08/18/2011	US20110201545 Gel based livestock feed, method of manufacture and use
08/18/2011	US20110201542 Myeloid Protein Activation of Anti-Inflammatory and Anti-Hypoxic Pathway
08/18/2011	US20110201092 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
08/18/2011	US20110201029 Il-13 receptor antibodies
08/18/2011	US20110200692 Use of a cinnamon bark extract for treating amyloid-associated diseases
08/18/2011	US20110200691 Medicine for Filterable Virus Infections and Its Processing Method
08/18/2011	US20110200683 Hydrogen peroxide solution producing first aid substance, packaging, and treatment
08/18/2011	US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
08/18/2011	US20110200674 Antimicrobial foam and method of manufacture
08/18/2011	US20110200668 Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics
08/18/2011	US20110200667 Veterinary pharmaceutical formulacion that comprises an rna recombinant particle that encodes for a cu/zn superoxide dismutase protein of ruminant pathogenic bacteria and at least one rna alphavirus belonging to the semliki forest virus family
08/18/2011	US20110200657 Methods of using nanoemulsion compositions having anti-inflammatory activity
08/18/2011	US20110200638 Bacterial vaccine
08/18/2011	US20110200637 Immunizing Compositions and Methods of Use
08/18/2011	US20110200636 Method for improving the breadth of the immune response to diverse strains and clades of hiv
08/18/2011	US20110200634 Immunogenic formulation
08/18/2011	US20110200633 Cytomegalovirus Surface Protein Complex for Use in Vaccines and as a Drug Target
08/18/2011	US20110200631 Lawsonia intracellularis vaccines
08/18/2011	US20110200630 Live attenuated virus vaccines for la crosse virus and other bunyaviridae
08/18/2011	US20110200628 Chimeric Proteins that Induce Effects Directed Against Viruses
08/18/2011	US20110200623 Polypeptide complex comprising non-peptidyl polymer having three functional ends
08/18/2011	US20110200616 Immunizing Compositions and Methods of Use
08/18/2011	US20110200615 Antibodies that Neutralize Botulinum Neurotoxins
08/18/2011	US20110200614 Anthrax specific antibodies
08/18/2011	US20110200613 Use of B Cell Expansion Agents in Generating Antibodies
08/18/2011	US20110200603 New antigens for paratuberculosis diagnosis and vaccination
08/18/2011	US20110200594 Functionalized polypeptides
08/18/2011	US20110200592 Methods For Reducing Viral Load in HIV-1 Infected Patients
08/18/2011	US20110200591 Products and methods to prevent infections
08/18/2011	US20110200589 Deconvolution method
08/18/2011	US20110200573 Methods of inhibiting retrovirus replication and infectivity
08/18/2011	US20110200570 Composition and Method for Treating Infections and Promoting Intestinal Health
08/18/2011	US20110200561 Method for Bacteriophage Delivery and Amplification
08/18/2011	US20110200558 Treatment or Prevention of Hepatitis C with Immunomodulator Compounds
08/18/2011	US20110200554 Therapeutic agent for hepatitis c
08/18/2011	US20110200553 Compounds and methods for the treatment or prevention of flavivirus infections
08/18/2011	US20110200541 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor
08/18/2011	DE102010007958A1 Wirkstoffkombinationen aus Acylarginaten und quaternären Ammoniumverbindungen Active compound combinations of Acylarginaten and quaternary ammonium compounds
08/18/2011	CA2789505A1 Free hexasaccharide isolated from several campylobacter species
08/18/2011	CA2789432A1 Serologic correlates of protection against bacillis anthracis infection

1 ... 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 ... 1798